AJP Legacy AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 204: 833-836, 1963;
0002-9513/63 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guroff, G.
Right arrow Articles by Steenbock, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guroff, G.
Right arrow Articles by Steenbock, H.

Citrate and action of vitamin D on calcium and phosphorus metabolism

Gordon Guroff 1, Hector F. DeLuca 1, and Harry Steenbock 1

1 Department of Biochemistry, University of Wisconsin, Madison, Wisconsin

Pantothenic acid and pyridoxine deficiencies in rats greatly minimized the rise in serum citrate following vitamin D administration without affecting the rise in serum calcium, serum phosphorus, and femur ash. In addition, pyridoxine deficiency reduced the response of bone citrate to the administration of vitamin D. The administration of cortisone acetate to rats on a low-calcium diet completely prevented the response of serum and bone citrate to vitamin D administration while having no effect on the response of serum calcium to vitamin D. These findings make it unlikely that an elevated citrate content of extracellular fluid and bone mediates the basic effects of vitamin D on mineral metabolism.

Note:
With the Technical Assistance of Daniel May

Submitted on October 11, 1962




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Theodoropoulos, C. Demers, J.-L. Petit, and M. Gascon-Barre
High sensitivity of rat hepatic vitamin D3-25 hydroxylase CYP27A to 1,25-dihydroxyvitamin D3 administration
Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E138 - E147.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. F. Holick, E J. Semmler, H. K. Schnoes, and H. F. Deluca
1agr-Hydroxy Derivative of Vitamin D3: A Highly Potent Analog of 1agr,25-Dihydroxyvitamin D3
Science, April 13, 1973; 180(4082): 190 - 191.
[Abstract] [PDF]


Home page
ScienceHome page
M. F. Holick, M. Garabedian, and H. F. DeLuca
5,6-Trans-25-Hydroxycholecalciferol: Vitamin D Analog Effective on Intestine of Anephric Rats
Science, June 16, 1972; 176(4040): 1247 - 1248.
[Abstract] [PDF]


Home page
ScienceHome page
M. F. Holick, M. Garabedian, and H. F. DeLuca
1,25-Dihydroxycholecalciferol: Metabolite of Vitamin D3 Active on Bone in Anephric Rats
Science, June 9, 1972; 176(4039): 1146 - 1147.
[Abstract] [PDF]


Home page
ScienceHome page
R. Gray, I. Boylf, and H. F. Deluca
Vitamin D Metabolism: The Role of Kidney Tissue
Science, June 18, 1971; 172(3989): 1232 - 1234.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1963 by the American Physiological Society.